This is my fourth BioMarin article following 01/2025's "BioMarin Pharmaceuticals: Share Downdraft Combined With VOXZOGO ...
BioMarin Pharmaceutical, a San Rafael biotech company known for treating extremely rare diseases, said Wednesday it’s laying off 225 workers, most of whom live and work in California. The cuts come ...
Some investors are considering whether BioMarin Pharmaceutical's current share price reflects its underlying value, or if the market may be overlooking certain factors. The stock last closed at US$54.
Pfizer and BioMarin have pulled their hemophilia gene therapies, citing low demand. To prepare for his presentation at the ...
Pfizer announced in February 2025 that it was taking Beqvez (fidanacogene elaparvovec), its gene therapy for hemophilia B, ...
BioMarin Pharmaceutical BMRN reported third-quarter 2025 adjusted earnings per share (EPS) of 12 cents against the Zacks Consensus Estimate of a loss of 15 cents. Quarterly earnings plummeted nearly ...
BioMarin Pharmaceutical BMRN announced that it entered a definitive agreement to acquire all outstanding shares of Amicus Therapeutics FOLD for $14.50 per share in cash, totaling $4.8 billion. The ...
VOXZOGO contribution to full-year 2025 Total Revenues expected to be in the range of $900 million to $950 million. Refer to Non-GAAP Information beginning on page 10 of this press release for ...
SAN RAFAEL, Calif., April 2, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (BMRN) today announced that the Phase 3 PEGASUS trial evaluating PALYNZIQ ® (pegvaliase-pqpz) met its primary efficacy ...
BioMarin Pharmaceutical's (NASDAQ: BMRN) website doesn't show any scheduled events on its calendar over the next month. However, that means nothing. The drugmaker will almost certainly report its 2025 ...
After previously floating the possibility of divesting Roctavian, BioMarin has decided to keep the hemophilia A gene therapy—but with a narrowed focus and cost cuts planned across the drug’s R&D, ...
A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results